EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability

Qin Yang, Qin Wan, Zhen Wang

Scientific Reports · 02.12.2024 · 14 (1)

DOI: 10.1038/s41598-024-81034-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 02.12.2024. Verfasst von Qin Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The people's Hospital of Leshan, Leshan, 614000, Sichuan, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Curcumin, Toll-Like Receptor 4, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder closely associated with chronic inflammation. Curcumin, a polyphenolic lipophilic compound, has been shown to improve the intestinal mucosal barrier and reduce low-grade systemic inflammation. This study aimed to assess the effects of curcumin on attenuation of PCOS in a mouse model and to explore the underlying mechanisms involved. C57BL/6J mice were divided into 4 groups (n = 15 per group): CON: control group, CON/CUR: CON with curcumin group, MOD: model group, MOD/CUR: MOD with curcumin group. The MOD and MOD/CUR groups were injected with dehydroepiandrosterone (DHEA) (6 mg/100 g BW) dissolved in soybean oil to induce a PCOS-like state. After curcumin intervention (200 mg/kg) for 45 days, the mice were euthanized for analysis of various physiological and biochemical parameters. In MOD/CUR group, significant decreases in body weight (BW) (p = 0.0254), testosterone (T) levels (p = 0.0052), luteinizing hormone (LH) levels (p = 0.0438), and the LH/follicle-stimulating hormone (FSH) (p = 0.0271) levels were observed, while estradiol (E2) (p = 0.0415) level and insulin sensitivity (p = 0.0441) were increased. Histological examination (HE) staining of ovarian and colon tissues showed that curcumin ameliorated both PCOS-associated morphological changes and colon tissue pathology. Western blot and immunohistochemistry analyses of colon tissues revealed increased levels of tight junction proteins, ZO-1 (Western blot, p = 0.0360; immunohistochemistry, p = 0.0273) and occluding (Western blot, p = 0.0189; immunohistochemistry, p = 0.0224) in the MOD/CUR group. Additionally, inflammatory indicators from plasma and ovary, including IL-17 A (plasma, p = 0.0120; ovary, p = 0.0414), IL-6 (plasma, p = 0.0344; ovary, p = 0.0379), TNF-α (plasma, p = 0.0078; ovary, p = 0.0488), and lipopolysaccharides (LPS) (plasma, p = 0.0144), were decreased, while IL-10 (plasma, p = 0.0270; ovary, p = 0.0267) was increased in MOD/CUR group. The levels of NF-κB p65 (p = 0.0229), TLR-4 (p = 0.0462) and MyD88 (p = 0.0152) in ovarian tissues were significantly increased in MOD/CUR group. Our results revealed that curcumin alleviates PCOS by inhibiting TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. These findings suggest that curcumin may provide a potential clinical approach for managing PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeCurcuminToll-Like Receptor 4Myeloid Differentiation Factor 88Signal TransductionIntestinal MucosaNF-kappa BAnimalsFemaleMicePermeabilityMice, Inbred C57BLDisease Models, AnimalIntestinal Barrier Function

Stichwörter der Autor:innen

CurcuminIntestinal mucosal permeabilityPCOSTLR4/MyD88/NF-κB

Substanzen

CurcuminToll-Like Receptor 4Myeloid Differentiation Factor 88NF-kappa BTlr4 protein, mouseMyd88 protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology, The people's Hospital of Leshan, Leshan, 614000, Sichuan, China.
  • Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, Taiping Street 25, Jiangyang District, Luzhou, 646000, Sichuan, China.
  • Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, Taiping Street 25, Jiangyang District, Luzhou, 646000, Sichuan, China. wanqin360@swmu.edu.cn.
  • Department of Gastroenterology, The people's Hospital of Leshan, NO.238 Baita Street, Shizhong District, Leshan, 614000, Sichuan, China. sciwangzhen@163.com.

Zitieren

APA

Yang, Q., Wan, Q., & Wang, Z. (2024). Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-81034-5

Vancouver

Yang Q, Wan Q, Wang Z. Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-81034-5

BibTeX
@article{Yang2024,
  author = {Yang, Qin and Wan, Qin and Wang, Zhen},
  title = {Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability},
  journal = {Scientific Reports},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1038/s41598-024-81034-5}
}
Kostenlos starten →